Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma

Published:2002-03 Issue:4 Volume:112 Page:262-268
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Wirth Andrew,Seymour John F,Hicks Rodney J,Ware Robert,Fisher Richard,Prince Miles,MacManus Michael P,Ryan Gail,Januszewicz Henry,Wolf Max

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Residual mass in lymphoma may not be residual disease;Canellos;J Clin Oncol,1988

2. Results of the 1988–1989 Patterns of Care Study process survey for Hodgkin’s disease;Smitt;Int J Radiat Oncol Bio Phys,1999

3. The stage is set for the diffusion of positron emission tomography in oncology;Morris;Med J Aust,1999

4. Functional imaging of Hodgkin’s disease with FDG-PET and gallium-67;Willkomm;Nuklearmedizin,1998

5. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium 67 citrate imaging for detection of lymphoma;Paul;J Nucl Med,1987

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positron emission tomography/computed tomography in the management of Hodgkin and B‐cell non‐Hodgkin lymphoma: An update;Cancer;2021-07-19

2. Gallium: New developments and applications in radiopharmaceutics;Recent Highlights I;2021

3. Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry;Radiology;2019-02

4. Lymphomes;Médecine Nucléaire;2019-01

5. Interim Functional Imaging Is an Independent Predictor of Progression-free Survival in Advanced Classical Hodgkin Lymphoma – A Real-world Analysis;Clinical Lymphoma Myeloma and Leukemia;2019-01